Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Atea Pharmaceuticals, Inc.
Market Cap
$412.94M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$415.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$417.82M
Net Profit Margin
-391.90%
TTM Avg
-78.17%
3Y Avg
-42.66%
5Y Avg
-429.16%
Market Cap
$405.64M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$419.46M
Net Profit Margin
-57.42%
TTM Avg
-73.98%
3Y Avg
-95.04%
5Y Avg
-95.04%
Market Cap
$437.37M
Net Profit Margin
-157.32%
TTM Avg
-564.37%
3Y Avg
-610.78%
5Y Avg
-554.09%
Market Cap
$387.87M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-102.82%
5Y Avg
-175.43%
Market Cap
$445.71M
Net Profit Margin
0.00%
TTM Avg
-90.86%
3Y Avg
-351.90%
5Y Avg
-2330.90%
Market Cap
$379.26M
Net Profit Margin
-81.04%
TTM Avg
-157.37%
3Y Avg
-379.90%
5Y Avg
-317.33%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. (AVIR) | $412.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $415.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $417.82M | -391.90% | -78.17% | -42.66% | -429.16% |
| Shoulder Innovations, Inc. (SI)vs › | $405.64M | -58.33% | -67.34% | -66.78% | -66.78% |
| Carlsmed, Inc. (CARL)vs › | $419.46M | -57.42% | -73.98% | -95.04% | -95.04% |
| Editas Medicine, Inc. (EDIT)vs › | $437.37M | -157.32% | -564.37% | -610.78% | -554.09% |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $387.87M | 0.00% | 0.00% | -102.82% | -175.43% |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | 0.00% | -90.86% | -351.90% | -2330.90% |
| Canopy Growth Corporation (CGC)vs › | $379.26M | -81.04% | -157.37% | -379.90% | -317.33% |
| Assembly Biosciences, Inc. (ASMB)vs › | $452.63M | -0.06% | -74.67% | -251.03% | -526.51% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 60.95% |
| 2021-09-30 | -85.93% |
| 2021-06-30 | 2.55% |
| 2021-03-31 | 46.55% |
| 2020-12-31 | 42.47% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
